• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者心房颤动的预测列线图模型:危险因素与预后的综合分析

Predictive nomogram models for atrial fibrillation in COPD patients: A comprehensive analysis of risk factors and prognosis.

作者信息

Huang Tao, Huang Xingjie, Cui Xueying, Dong Qinghua

机构信息

Department of Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541100, P.R. China.

Department of Cardiovascular Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541100, P.R. China.

出版信息

Exp Ther Med. 2024 Feb 28;27(4):171. doi: 10.3892/etm.2024.12459. eCollection 2024 Apr.

DOI:10.3892/etm.2024.12459
PMID:38476891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10928814/
Abstract

The aim of the present study was to identify the independent risk factors and prognostic indicators for atrial fibrillation (AF) in patients with chronic obstructive pulmonary disease (COPD) and to develop predictive nomogram models. This retrospective study included a total of 286 patients with COPD who were admitted to the Second Affiliated Hospital of Guilin Medical College between January 2020 and May 2022. The average age of the patients was 77.11±8.67 years. Based on the presence or absence of AF, the patients were divided into two groups: The AF group (n=87) and the non-AF group (n=199). Logistic regression analysis was conducted to identify variables with significant differences between the two groups. Nomogram models were constructed to predict the occurrence of AF in COPD patients and to assess prognosis. Survival analysis was performed using the Kaplan-Meier method. The follow-up period for the present study extended until April 31, 2023. Survival time was defined as the duration from the date of the interview to the date the participant succumbed or the end of the follow-up period. In the present study, age, uric acid (UA) and left atrial diameter (LAD) were found to be independent risk factors for the development of AF in patients diagnosed with COPD. The stepwise logistic regression analysis revealed that age had an odds ratio (OR) of 1.072 [95% confidence interval (CI): 1.019-1.128; P=0.007], UA had an OR of 1.004 (95% CI: 1.001-1.008; P=0.010) and LAD had an OR of 1.195 (95% CI: 1.098-1.301; P<0.001). Univariate and multivariate Cox regression analysis revealed that LAD and UA were independent prognostic factors for long-term mortality in COPD patients with AF. LAD had a hazard ratio (HR) of 1.104 (95% CI: 1.046-1.165; P<0.001) and UA had an HR of 1.004 (95% CI: 1.000-1.008; P=0.042). Based on these findings, predictive nomogram models were developed for AF in COPD patients, which demonstrated good discrimination ability with an area under the curve of 0.886. The prognostic nomogram for COPD patients with AF also showed good predictive accuracy with a concordance index of 0.886 (95% CI: 0.842-0.930). These models can provide valuable information for risk assessment and prognosis evaluation in clinical practice. Age, UA and LAD are independent risk factors for AF in COPD patients. The developed nomogram models provide a reliable tool for predicting AF in COPD patients and for prognosis assessment.

摘要

本研究的目的是确定慢性阻塞性肺疾病(COPD)患者发生心房颤动(AF)的独立危险因素和预后指标,并建立预测列线图模型。这项回顾性研究共纳入了2020年1月至2022年5月期间在桂林医学院第二附属医院住院的286例COPD患者。患者的平均年龄为77.11±8.67岁。根据是否存在AF,将患者分为两组:AF组(n = 87)和非AF组(n = 199)。进行逻辑回归分析以确定两组之间存在显著差异的变量。构建列线图模型以预测COPD患者AF的发生并评估预后。采用Kaplan-Meier法进行生存分析。本研究的随访期延长至2023年4月31日。生存时间定义为从访谈日期到参与者死亡日期或随访期结束的持续时间。在本研究中,年龄、尿酸(UA)和左心房直径(LAD)被发现是诊断为COPD患者发生AF的独立危险因素。逐步逻辑回归分析显示,年龄的比值比(OR)为1.072 [95%置信区间(CI):1.019 - 1.128;P = 0.007],UA的OR为1.004(95% CI:1.001 - 1.008;P = 0.010),LAD的OR为1.195(95% CI:1.098 - 1.301;P < 0.001)。单因素和多因素Cox回归分析显示,LAD和UA是COPD合并AF患者长期死亡率的独立预后因素。LAD的风险比(HR)为1.104(95% CI:1.046 - 1.165;P < 0.001),UA的HR为1.004(95% CI:1.000 - 1.008;P = 0.042)。基于这些发现,为COPD患者开发了AF预测列线图模型,其曲线下面积为0.886,显示出良好的区分能力。COPD合并AF患者的预后列线图也显示出良好的预测准确性,一致性指数为0.886(95% CI:0.842 - 0.930)。这些模型可为临床实践中的风险评估和预后评估提供有价值的信息。年龄、UA和LAD是COPD患者发生AF的独立危险因素。所开发的列线图模型为预测COPD患者的AF和评估预后提供了可靠的工具。

相似文献

1
Predictive nomogram models for atrial fibrillation in COPD patients: A comprehensive analysis of risk factors and prognosis.慢性阻塞性肺疾病患者心房颤动的预测列线图模型:危险因素与预后的综合分析
Exp Ther Med. 2024 Feb 28;27(4):171. doi: 10.3892/etm.2024.12459. eCollection 2024 Apr.
2
A Predictive Nomogram of In-Hospital Mortality After 48 h for Atrial Fibrillation Patients in the Coronary Care Unit.冠心病监护病房中房颤患者 48 小时内住院死亡率的预测列线图。
Clin Cardiol. 2024 Sep;47(9):e70017. doi: 10.1002/clc.70017.
3
Influence of atrial fibrillation on cardiac prognosis in chronic obstructive pulmonary disease.心房颤动对慢性阻塞性肺疾病心脏预后的影响。
Indian Heart J. 2019 Jan-Feb;71(1):7-11. doi: 10.1016/j.ihj.2018.11.009. Epub 2018 Dec 1.
4
Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study.心房颤动患者慢性阻塞性肺疾病的临床特征及预后意义:一项多中心心房颤动注册研究的结果
J Am Med Dir Assoc. 2014 Aug;15(8):576-81. doi: 10.1016/j.jamda.2014.04.009. Epub 2014 Jun 2.
5
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.慢性阻塞性肺疾病对心房颤动预后的影响:欧洲观察性研究计划心房颤动试点调查(EORP-AF)总登记处的报告
Am Heart J. 2016 Nov;181:83-91. doi: 10.1016/j.ahj.2016.08.011. Epub 2016 Aug 27.
6
Prediction of individual mortality risk among patients with chronic obstructive pulmonary disease: a convenient, online, individualized, predictive mortality risk tool based on a retrospective cohort study.预测慢性阻塞性肺疾病患者的个体死亡风险:一种基于回顾性队列研究的便捷、在线、个体化、预测死亡风险工具。
PeerJ. 2022 Dec 6;10:e14457. doi: 10.7717/peerj.14457. eCollection 2022.
7
Nomogram to predict recurrence risk factors in patients with non-valvular paroxysmal atrial fibrillation after catheter radiofrequency ablation.列线图预测导管射频消融术后非瓣膜性阵发性心房颤动患者的复发风险因素。
Echocardiography. 2024 Mar;41(3):e15779. doi: 10.1111/echo.15779.
8
Development and Validation of a Novel Prognostic Model Predicting the Atrial Fibrillation Recurrence Risk for Persistent Atrial Fibrillation Patients Treated with Nifekalant During the First Radiofrequency Catheter Ablation.开发并验证一种新的预测模型,用于预测在第一次射频导管消融治疗中使用尼非卡兰的持续性心房颤动患者的心房颤动复发风险。
Cardiovasc Drugs Ther. 2023 Dec;37(6):1117-1129. doi: 10.1007/s10557-022-07353-9. Epub 2022 Jun 22.
9
Competitive interaction between chronic obstructive pulmonary disease and CHADS-VASc score in predicting incident atrial fibrillation.慢性阻塞性肺疾病与 CHADS-VASc 评分在预测新发心房颤动中的竞争作用。
Int J Cardiol. 2018 Mar 15;255:74-79. doi: 10.1016/j.ijcard.2017.11.036. Epub 2017 Nov 20.
10
Study on the correlation between red cell distribution width, homocysteine, lipoprotein(a), and left atrial diameter in newly diagnosed nonvalvular atrial fibrillation patients.探讨新诊断的非瓣膜性心房颤动患者红细胞分布宽度、同型半胱氨酸、脂蛋白(a)与左心房内径的相关性。
Eur Rev Med Pharmacol Sci. 2024 Jan;28(1):319-326. doi: 10.26355/eurrev_202401_34919.

本文引用的文献

1
Hypertension management in patients with cardiovascular comorbidities.心血管合并症患者的高血压管理。
Eur Heart J. 2023 Jun 20;44(23):2066-2077. doi: 10.1093/eurheartj/ehac395.
2
Aging-suppressor Klotho: Prospects in diagnostics and therapeutics.衰老抑制因子 Klotho:在诊断和治疗中的前景。
Ageing Res Rev. 2022 Dec;82:101766. doi: 10.1016/j.arr.2022.101766. Epub 2022 Oct 22.
3
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
4
Environmental factors and risk of gout.环境因素与痛风的风险。
Environ Res. 2022 Sep;212(Pt C):113377. doi: 10.1016/j.envres.2022.113377. Epub 2022 Apr 29.
5
U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia.尿酸与全因死亡率的 U 型关联及其对高尿酸血症临床管理的影响。
Redox Biol. 2022 May;51:102271. doi: 10.1016/j.redox.2022.102271. Epub 2022 Feb 17.
6
Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics.心房颤动:发病机制、易患因素和遗传学。
Int J Mol Sci. 2021 Dec 21;23(1):6. doi: 10.3390/ijms23010006.
7
Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.评估 2009 年和 2019 年治疗患有多种慢性病的老年人的指南推荐药物的假设自付费用。
JAMA Intern Med. 2022 Feb 1;182(2):185-195. doi: 10.1001/jamainternmed.2021.7457.
8
Current evidence on the safety and efficacy of combined atrial fibrillation ablation and left atrial appendage closure.目前关于房颤消融联合左心耳封堵安全性和有效性的证据。
Curr Opin Cardiol. 2022 Jan 1;37(1):74-79. doi: 10.1097/HCO.0000000000000913.
9
Left atrial appendage closure - Current status and future directions.左心耳封堵术——现状与未来方向。
Prog Cardiovasc Dis. 2021 Nov-Dec;69:101-109. doi: 10.1016/j.pcad.2021.11.013. Epub 2021 Nov 27.
10
The Coexistence of Chronic Obstructive Pulmonary Disease and Heart Failure.慢性阻塞性肺疾病与心力衰竭的共存
Cureus. 2021 Aug 23;13(8):e17387. doi: 10.7759/cureus.17387. eCollection 2021 Aug.